Feels like NOW and MU are clashing over strategy.
In payments, NOW’s bank model competes with MU’s fintech angle, but MU’s partnerships with banks could offset the lack of a physical branch. If MU keeps growing merchant volumes, it might outpace NOW’s deposit-driven growth.
I'm on the sidelines for now. The $30 talk excites me, but I don't want to get caught in a fade. I'd rather wait for a pullback and see if China demand or margins actually improve.
Everyone's cheering the move, but NIO's momentum feels fragile; I'd expect a pause before any real breakout.
Market hype again, feels like chasing NIO spikes.
Hard to buy a 29.3 pop without higher rates and thin liquidity. If funding tightens, CELH could fade fast.
Biotech names staying choppy; CELH drifts with peers.
Quick bounce or fakeout before next leg?
